Adamed Pharma S.A. G.L. Pharma GmbH

Poland

All drugs from this manufacturer

  • RIVAHIB

    The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease following an acute coronary syndrome. It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2.5 mg

    ATC: B01AF01

  • The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat venous thrombosis in the legs and pulmonary vessels, as well as to prevent the recurrence of these clots.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01AF01

  • Varodoax is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent the recurrence of blood clots in the leg veins and pulmonary vessels. In children and adolescents under 18 years of age (weighing more than 30 kg), it is also used to treat clots following initial treatment with injectable medications.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01AF01

  • Varodoax is used in adults to prevent strokes and other blood clots (in non-valvular atrial fibrillation) and to treat and prevent the recurrence of blood clots in the leg veins and pulmonary vessels. In children and adolescents under 18 years of age (weighing more than 30 kg), it is used for the treatment and prevention of clots after at least 5 days of treatment with injections.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01AF01